Real-world data survival outcomes of first line immunotherapy with pembrolizumab in high expressers with stage IV non-small cell lung cancer
Authors
Vladimir Stojsic
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Bojan Zaric
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Petar Simurdic
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Tomi Kovacevic
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Darijo Bokan
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Jelena Djekic Malbasa
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Tatjana Sarcev
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Goran Stojanovic
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Faculty of Pharmacy, University Business Academy in Novi Sad, Novi Sad, Serbia
Daliborka Bursac
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Clinic for Thoracic Oncology, Institute for Pulmonary Diseases of Vojvodina, Sremska Kamenica, Serbia
Borislava Nikolin
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia
Oncology Institute of Vojvodina, Sremska Kamenica, Serbia
Language: English
Page range: 450 - 458
Submitted on: Mar 23, 2026
Accepted on: May 22, 2026
Published on: Sep 7, 2026
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Vladimir Stojsic, Bojan Zaric, Petar Simurdic, Tomi Kovacevic, Darijo Bokan, Jelena Djekic Malbasa, Tatjana Sarcev, Goran Stojanovic, Daliborka Bursac, Borislava Nikolin, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.